7[1]Bottalico JN. Diabetes in pregnancy. J AM Osteopath Assoc,2001,101(2supp1) :S10～ 13.
8[2]Mark B, Landon. Diabetes mellitus and other endocrine diseases.In: Steven G. Gabbe, Jennifer R. Nieby1, Joe Leigh Simpson, Eds.Obstetrics normal and problem pregnancies. Second edition. New York :Churchill Livingstone Inc, 1991,1097～1136.
9[3]Koren G. Glyburide and feal safety;transplacental pharmacokinetic considerations. Report Toxical, 2001,15 ( 3 ): 227 ～229.
10[4]Ladyzynski P, Wojcicki JM, Krzymien J,et al. Teletransmission supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant woman. Technical assessment during 3years′ application. lnt J Artif Organs. 2000,24(3) :157～163.
4Crevoisier C,Zerrc P,Calvi2Gries F,et al.Effects of food on the pharmacokinetics of levodopa in a dual2release formulation[J].Eur J Pharm Biopharm,2003,55(1):71～76
5Morita E,Mizuno N,Nishikata M,et al.Effect of gastrointestinal mat2 uration on absorption of beta21actam antibiotics[J].J Pharm Sci,1992,81(4):337～340
6Robert F,Kaiko.The effect of food intake on the pharmacokinetics of sustained2release morphine sulfate capsules[J].Clin Ther,1997,19(2):296～303
7Wei-dong Li.Pharmacology teaching and its reform in china[J].Acta pharmacological Sinica.2004,9 (04):113 ～ 136
